#ICYMI: Three of the most reliable factors contributing to #DrugShortages are 💊manufacturing complexity; 💊low drug prices; and 💊production concentration. Read more from #USP experts and others who shared insights at our event in partnership with American Cancer Society Cancer Action Network + American Cancer Society. ⤵️

Kevin Webb, COO, was a panelist for The Wilson Center and U.S. Pharmacopeia's “Building a High Quality US-Mexico Pharmaceutical Supply Chain” seminar. You can watch the full event here: bit.ly/USMexicoPharma…

We are excited to share our agenda for our event, Pathway to Build Supply Chain Resilience for Critical Drugs. 📌 Highlights:  🔷 Date: November 8th  🔷 Location: St. Louis, MO 🔷 Registration: apicenter.org/events

NEW CUTTING-EDGE FACILITY COMING TO NORTH STL — A milestone moment was reached this morning as @GovParsonMO, Mayor Cara Spencer & other leaders gathered to break ground for the new home of the Advanced Manufacturing Innovation Center St. Louis. greaterstlinc.com/news/stl2030-j…

We released a new #whitepaper informed by experts in the #pharmaceutical industry, outlining recommendations for reshoring the manufacture of essential, life-saving pharmaceuticals. Read the paper here: apicenter.org/news-updates/w…

#ATTN: We're pleased to announce a strategic collaboration with API Innovation Center to help end #DrugShortages in America. Together, we'll harness #SupplyChain insights + advanced technologies to ensure access to critical meds. Read more: ow.ly/z3L050QAE1O

We're thrilled to work with U.S. Pharmacopeia to help ensure access to critical medicines through #supplychain resilience and #advanced manufacturing!

Congratulations to MilliporeSigma on this opening. This is an excellent addition to the St. Louis region!

The API Innovation Center has reached a major milestone in bringing the production of lomustine, a critical cancer drug, to the U.S. It's an important step in positioning Missouri as a hub for essential pharmaceutical manufacturing. Congrats! Read more ⬇️ yhoo.it/3VSy1FV

Our COO was at CPHI North America this week! Kevin Webb participated in a panel discussion on "Reshoring U.S. Pharma: The Realities" as part of the Supply Chain Economy track sponsored by U.S. Pharmacopeia Read more: contractpharma.com/live-from-show…

We are proud to be working with the Missouri Chamber on a strategic plan to increase our state’s manufacturing competitiveness. Register for a FREE roundtable near you: mochamber.com/event/manufact…

Drug shortages and supply chain issues continue to threaten patients in need of life-saving treatments. We are proud to participate in discussions around Advanced Manufacturing Technologies and supply chain reliability with the Duke-Margolis ReVAMP Drug Supply Chain Consortium.

We’re excited to be in STL for the Advanced Pharmaceutical Manufacturing Technology Conference, co-hosted by API Innovation Center and the Missouri Technology Alliance. The Missouri Chamber is proud to support this event and help foster an environment that attracts & retains tech

On September 25, 2024, the Washington University Center for Analytics and Business Insights (CABI) is partnering with the API Innovation Center to discuss the future of pharmaceutical manufacturing in Missouri. Register now 🔗 bit.ly/4dXsAvM #washu #washuolin

Under Defense Production Act Title III, we’re working to reshore pharmaceutical manufacturing. Today, we announced a $14M award to increase the biomanufacturing of key starting materials (KSM) & active pharmaceutical ingredients (APIs) in the US. aspr.hhs.gov/newsroom/Pages…

We are thrilled to share we recently advised client API Innovation Center on their successful application to obtain funding by the Administration for Strategic Preparedness and Response’s Center for Industrial Base Management & Supply Chain: polsinelli.com/news/polsinell…. #healthcare

The API Innovation Center's efforts to strengthen the U.S. pharmaceutical supply chain & make #MO a leader in #API production is also expected to strengthen Missouri’s #economy. bit.ly/4dQp1GW #Bioscience #HumanHealth #Healthcare #PharmaceuticalManufacturing #STL

St. Louis is leading the fight against U.S. drug shortages by bringing active pharmaceutical ingredient production back to the U.S. through the API Innovation Center. HEC Media hecmedia.org/posts/fighting… #STLMade

🚨 CONSUMER ALERT: Right now 25% of generic prescriptions in the U.S. are from facilities with an FDA violation according to API Innovation Center. Why? Because they are made in Communist China and India in facilities that fail to meet our standards. It’s not safe—we must fix this